The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.

about

Engineering CAR-T Cells for Improved Function Against Solid Tumors

P2860

Q58694793-B6E5CB72-B93A-4FC8-8D97-E4FC8B820C95

P2860

The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.

Item

http://www.wikidata.org/entity/Q49565011

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The CXCR4-STAT3-IL-10 Pathway ...... Is Modulated by Lenalidomide.

@en

The CXCR4-STAT3-IL-10 Pathway ...... Is Modulated by Lenalidomide.

@nl

type

Item

label

The CXCR4-STAT3-IL-10 Pathway ...... Is Modulated by Lenalidomide.

@en

The CXCR4-STAT3-IL-10 Pathway ...... Is Modulated by Lenalidomide.

@nl

prefLabel

The CXCR4-STAT3-IL-10 Pathway ...... Is Modulated by Lenalidomide.

@en

The CXCR4-STAT3-IL-10 Pathway ...... Is Modulated by Lenalidomide.

@nl

P1476

The CXCR4-STAT3-IL-10 Pathway ...... Is Modulated by Lenalidomide.

@en

P2093

Abdullah Saleh Alsuliman

http://www.w3.org/2001/XMLSchema#string

Catherine Sobieski

http://www.w3.org/2001/XMLSchema#string

David Harris

http://www.w3.org/2001/XMLSchema#string

Elif Gokdemir

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Shpall

http://www.w3.org/2001/XMLSchema#string

Enli Liu

http://www.w3.org/2001/XMLSchema#string

Hila Shaim

http://www.w3.org/2001/XMLSchema#string

Jan Burger

http://www.w3.org/2001/XMLSchema#string

Katayoun Rezvani

http://www.w3.org/2001/XMLSchema#string

Kayo Kondo

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism of action of lenalidomide in hematological malignancies

Efficacy of lenalidomide in myelodysplastic syndromes.

C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia

STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells.

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma

T follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-prone MRL/lpr mice.

P304

1773

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.01773

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29379494

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

P932

5775272

http://www.w3.org/2001/XMLSchema#string

The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.

about

P2860

P2860

The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932